Atlas Trials

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Clinical trial NCT06926842 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06926842
Sponsor
Zealand Pharma
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
OverweightType 2 DiabetesObesity
Start date
2025-04-22
Primary completion
2026-08-13
Enrollment
221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.